Rock Hill, North Carolina Clinical Trials

A listing of Rock Hill, North Carolina clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 16 clinical trials
Open-label Trial in Parkinson's Disease (PD)

The purpose of this study is to evaluate the safety and efficacy of long-term administration of flexible doses of tavapadon in participants with Parkinson's Disease .

bradykinesia
amantadine
levodopa
carbidopa
Metrolina Neurological Associates and Diagnostic Center
 (5.0 away) Contact site
  • 0 views
  • 31 Jul, 2021
  • +3 other locations
A Study to Assess the Efficacy Safety and Tolerability of Brensocatib in Participants With Non-Cystic Fibrosis Bronchiectasis

The primary objective of this study is to evaluate the effect of brensocatib at 10 mg and 25 mg compared with placebo on the rate of pulmonary exacerbations (PEs) over the 52-week treatment period.

USA036
 (5.0 away) Contact site
  • 3 views
  • 01 Aug, 2021
  • +258 other locations
Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (LOGOS)

This is a variable length study to evaluate the efficacy and safety of budesonide/glycopyrronium/formoterol inhaler in adults and adolescents with severe asthma inadequately controlled with standard of care.

Research Site
 (33.9 away) Contact site
  • 0 views
  • 21 Jul, 2021
  • +227 other locations
Registrational Trial to Compare Effectiveness of Two Digital Software Medical Devices as Adjunctive Oncology Treatment

This is a non-significant risk, double-blinded, randomized, registrational study to compare the effectiveness of two digital, software only, medical devices (SaMD) (attune and cerena) in reducing cancer-related anxiety and depression symptoms when used adjunctively with multidisciplinary (medical, psychosocial) oncology usual care regimens for up to 10 weeks. Study population will …

Carolina Blood and Cancer Care
 (3.3 away) Contact site
  • 0 views
  • 04 Aug, 2021
  • +8 other locations
A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease

This is a Phase 2/3 study that comprises 5 substudies designed to evaluate the efficacy, safety, and tolerability of oral etrasimod as therapy in adult participants with moderately to severely active Crohn's disease (CD) who are refractory or intolerant to at least 1 of the current therapies for CD (ie, …

tumor necrosis factor
budesonide
vedolizumab
tumour necrosis
immunosuppressive agents
Clinical Research of Rock Hill
 (3.3 away) Contact site
  • 63 views
  • 22 Jul, 2021
  • +157 other locations
Efficacy and Safety Study of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low Low or Intermediate Risk Myelodysplastic Syndromes (MDS) in ESA Na ve Subjects Who Require Red Blood Cell Transfusions

The study will be conducted in compliance with the International Council for Harmonisation (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use/Good Clinical Practice (GCP) and applicable regulatory requirements. This is an interventional active-controlled, open-label, randomized Phase 3 study to compare the efficacy and safety of luspatercept (ACE-536) …

bone marrow procedure
cancer
blood transfusion
erythropoietin
anemia
Carolina Blood and Cancer Care
 (3.3 away) Contact site
  • 289 views
  • 04 Aug, 2021
  • +258 other locations
Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With a History of Frequent Exacerbations

Phase 3 study to evaluate the efficacy and safety of a benralizumab in patients with moderate to very severe COPD with a history of frequent COPD exacerbations and elevated peripheral blood eosinophils (300/L). Eligible patients must have a history of 2 moderate and/or severe COPD exacerbations in the previous year …

antibiotics
severe chronic obstructive pulmonary disease
bronchodilator
corticosteroids
eosinophil count
Research Site
 (3.3 away) Contact site
  • 838 views
  • 04 Aug, 2021
  • +426 other locations
An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis

The purpose of this open-label extension (OLE) study is to evaluate the safety and efficacy of etrasimod in participants with moderately to severely active ulcerative colitis (UC) who previously received double-blinded treatment (either etrasimod 2 mg per day or placebo) during participation in one of two Phase 3 double-blinded, placebo-controlled …

Clinical Research of Rock Hill
 (3.3 away) Contact site
  • 133 views
  • 04 Aug, 2021
  • +391 other locations
Tezepelumab COPD Exacerbation Study

A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2a Study to Explore the Efficacy and Safety of Tezepelumab in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

bronchodilator
severe chronic obstructive pulmonary disease
copd exacerbation
ct scan
Research Site
 (3.3 away) Contact site
  • 130 views
  • 23 Jul, 2021
  • +107 other locations
Mepolizumab as Add-on Treatment IN Participants With COPD Characterized by Frequent Exacerbations and Eosinophil Level (MATINEE)

This is a multi-center, randomized, placebo-controlled, double-blind, parallel group study designed to confirm the benefits of mepolizumab treatment on moderate or severe exacerbations in COPD participants given as an add on to their optimized maintenance COPD therapy. The maximum duration of participant participation is approximately 57 weeks, consisting of 2 …

albuterol
muscarinic antagonists
eosinophil count
antibiotics
copd exacerbation
GSK Investigational Site
 (3.3 away) Contact site
  • 379 views
  • 24 Jul, 2021
  • +232 other locations